NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Amgen submits BLA for Infliximab biosimilar ABP 710 to FDA Amgen Inc. has officially submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)… bypharmanewsdailyDecember 18, 2018
